Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Cash and Short Term Investments

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Cash-and-Short-Term-Investments" stands at 739.68 Billion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash and Short Term Investments" stands at 739.68 Billion JPY. This represents an increase of 111.33 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -13.89 percent compared to the value the year prior.
The 1 year change in percent is -13.89.
The 3 year change in percent is -7.32.
The 5 year change in percent is 17.25.
The 10 year change in percent is 10.80.

The Serie's long term average value is 590.26 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 25.31 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2018, to it's latest available value, on 09/30/2025, is +219.54%.
The Serie's change in percent from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -23.45%.

Cash and Short Term Investments for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Short Term Investments905,699,262,464.00
LogoJohnson & Johnson - Cash and Short Term Investments486,508,953,600.00
LogoAbbVie Inc - Cash and Short Term Investments399,570,305,024.00
LogoRoche Holding AG - Cash and Short Term Investments317,433,206,677.55
LogoAstraZeneca PLC - Cash and Short Term Investments280,205,508,085.11